At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 46 enrolled
Drug / intervention
AI assisted insulin system +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Assess the Effect and Safety of Artificial Intelligence Assisted Insulin Titration System on Glucose Control in Type 2 Diabetes Mellitus Patients: A Single-center, Open-labeled, Parallel, Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating AI assisted insulin system and Physician based insulin regime for Type 2 Diabetes. Completed, enrolled 46 participants across 1 site.
Detailed Summary
This is a single-center, open-labeled, parallel group, randomized controlled trial to access the effect and safety of the Artificial Intelligence Assisted Insulin Titration System in patients with Type 2 Diabetes Mellitus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesChina
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedAug 2019
Enrollment StartSep 2019
Primary CompletionJan 2020
Study CompletionApr 2020
TodayJul 2026
First PostedAug 13, 2019
Enrollment StartSep 27, 2019
Primary CompletionJan 22, 2020
Study CompletionApr 15, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.9 years ago
Interventions
AI assisted insulin systemdrug
The patients receive the insulin regime set by AI assisted insulin titration system
Physician based insulin regimedrug
Patients receive the insulin regime recommended by physicians